Association of TLR9 polymorphisms with sporadic Parkinson's disease in Chinese Han population

Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China

(2014) Xin-su Wei et al.   YONSEI MEDICAL JOURNAL

Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender

(2013) M. I. Dominguez-Mozo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese

(2013) Ying-Li Wang et al.   Journal of Neuroinflammation

Involvement of toll-like receptor 9 polymorphism in cervical cancer development

(2012) Andrzej Roszak et al.   MOLECULAR BIOLOGY REPORTS

TLR9 −1237 T/C and TLR2 −194 to −174 del polymorphisms and the risk of Parkinson’s disease in the Greek population: a pilot study

(2012) Kallirhoe Kalinderi et al.   NEUROLOGICAL SCIENCES

NADPH oxidases: novel therapeutic targets for neurodegenerative diseases

(2012) Hui-Ming Gao et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Evaluating the role of Toll-like receptors in diseases of the central nervous system

(2011) Michael Carty et al.   BIOCHEMICAL PHARMACOLOGY

Genetics of Parkinsonʼs disease and essential tremor

(2011) Alexander Zimprich   CURRENT OPINION IN NEUROLOGY

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

(2011) F. Ros-Bernal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility

(2010) Saumya Pandey et al.   MOLECULAR BIOLOGY REPORTS

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Microglial activation and chronic neurodegeneration

(2010) Melinda E. Lull et al.   Neurotherapeutics